Debut af type 1-diabetes efter behandling med onlineordineret semaglutid

Laura Hasse; Rosa Dam Wærling; Baiba Hedegaard Hansen

doi:10.61409/V06250507

Debut af type 1-diabetes efter behandling med onlineordineret semaglutid

Translated title of the contribution: Onset of type 1 diabetes after treatment with online-prescribed semaglutide

Laura Hasse^*, Rosa Dam Wærling, Baiba Hedegaard Hansen

^*Corresponding author for this work

Abstract

A 49-year-old woman developed new-onset type 1 diabetes after initiating Wegovy (semaglutide) via an online clinic, without prior screening. She experienced rapid weight loss and hyperglycemia symptoms. Blood tests indicated high GAD65 and low C-peptide. The case underscores the need for biochemical screening and follow-up in digital obesity care.

Translated title of the contribution	Onset of type 1 diabetes after treatment with online-prescribed semaglutide
Original language	Danish
Article number	V06250507
Journal	Ugeskrift for Laeger
Volume	188
Issue number	8
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V06250507
Publication status	Published - 16 Feb 2026

Access to Document

10.61409/V06250507Licence: CC BY-NC-ND

Cite this

@article{4e3e3a9e9efc4335a52b27fca11bdf31,

title = "Debut af type 1-diabetes efter behandling med onlineordineret semaglutid",

abstract = "A 49-year-old woman developed new-onset type 1 diabetes after initiating Wegovy (semaglutide) via an online clinic, without prior screening. She experienced rapid weight loss and hyperglycemia symptoms. Blood tests indicated high GAD65 and low C-peptide. The case underscores the need for biochemical screening and follow-up in digital obesity care.",

author = "Laura Hasse and W{\ae}rling, \{Rosa Dam\} and Hansen, \{Baiba Hedegaard\}",

note = "Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2026",

month = feb,

day = "16",

doi = "10.61409/V06250507",

language = "Dansk",

volume = "188",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Debut af type 1-diabetes efter behandling med onlineordineret semaglutid

AU - Hasse, Laura

AU - Wærling, Rosa Dam

AU - Hansen, Baiba Hedegaard

N1 - Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2026/2/16

Y1 - 2026/2/16

N2 - A 49-year-old woman developed new-onset type 1 diabetes after initiating Wegovy (semaglutide) via an online clinic, without prior screening. She experienced rapid weight loss and hyperglycemia symptoms. Blood tests indicated high GAD65 and low C-peptide. The case underscores the need for biochemical screening and follow-up in digital obesity care.

AB - A 49-year-old woman developed new-onset type 1 diabetes after initiating Wegovy (semaglutide) via an online clinic, without prior screening. She experienced rapid weight loss and hyperglycemia symptoms. Blood tests indicated high GAD65 and low C-peptide. The case underscores the need for biochemical screening and follow-up in digital obesity care.

UR - https://www.scopus.com/pages/publications/105031190969

U2 - 10.61409/V06250507

DO - 10.61409/V06250507

M3 - Tidsskriftartikel

C2 - 41738100

AN - SCOPUS:105031190969

SN - 0041-5782

VL - 188

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 8

M1 - V06250507

ER -

Debut af type 1-diabetes efter behandling med onlineordineret semaglutid

Abstract

Access to Document

Other files and links

Fingerprint

Cite this